Related references
Note: Only part of the references are listed.Prostate-specific membrane antigen: a new potential prognostic marker of osteosarcoma
Chao Zeng et al.
MEDICAL ONCOLOGY (2012)
Prostate-Specific Membrane Antigen as a Potential Novel Vascular Target for Treatment of Glioblastoma Multiforme
A. Gabriella Wernicke et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2011)
Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers
Michael C. Haffner et al.
HUMAN PATHOLOGY (2009)
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Maggie C. U. Cheang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Phase I trial of the prostate-specific membrane antigen directed immunoconjugate MLN2704 in patients with progressive metastatic castration-resistant prostate cancer
Matthew D. Galsky et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Genes that distinguish physiological and pathological angiogenesis
Steven Seaman et al.
CANCER CELL (2007)
Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumors
Michael J. Morris et al.
CLINICAL CANCER RESEARCH (2007)
Vascular targeted therapy with anti-prostate-specific membrane antigen monoclonal antibody J591 in advanced solid tumors
Matthew I. Milowsky et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A dimeric peptide that binds selectively to prostate-specific membrane antigen and inhibits its enzymatic activity
Saurabh Aggarwal et al.
CANCER RESEARCH (2006)
NAAG peptidase inhibitors and their potential for diagnosis and therapy
J Zhou et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Phase I trial of 177lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancer
NH Bander et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Targeting novel antigens for prostate cancer treatment: focus on prostate-specific membrane antigen
SF Slovin
EXPERT OPINION ON THERAPEUTIC TARGETS (2005)
Radiolabeled small-molecule ligands for prostate-specific membrane antigen:: In vivo imaging in experimental models of prostate cancer
CA Foss et al.
CLINICAL CANCER RESEARCH (2005)
Is prostate-specific membrane antigen a multifunctional protein?
AK Rajasekaran et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)
Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase
MI Davis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Phase I trial of yttrium-90-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for androgen-independent prostate cancer
MI Milowsky et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Microvessel density as a prognostic factor in women with breast cancer: A systematic review of the literature and meta-analysis
B Uzzan et al.
CANCER RESEARCH (2004)
Targeted systemic therapy of prostate cancer with a monoclonal antibody to prostate-specific membrane antigen
NH Bander et al.
SEMINARS IN ONCOLOGY (2003)
Clinical translation of angiogenesis inhibitors
R Kerbel et al.
NATURE REVIEWS CANCER (2002)
The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis
AP Meert et al.
BRITISH JOURNAL OF CANCER (2002)
Share Paper
